Low-Dose Ketamine Aids Chronic Refractory Pain
Low-dose ketamine for chronic refractory pain shows therapeutic benefit and high tolerability, according to a recent study.
A study published online in Regional Anesthesia & Pain Medicine found that low-dose ketamine infusion therapy (KIT) has a high treatment completion rate and no adverse events reported.
- Treatment completion rate: 86.1%
- Patients received five or more infusions
- No adverse events reported
Researchers, including Hallie Tankha, Ph.D., from the Cleveland Clinic, evaluated the effectiveness of KIT for patients with chronic refractory pain.
Low-dose ketamine for chronic refractory pain shows therapeutic benefit and high tolerability.
Author's summary: Low-dose ketamine aids chronic pain relief.